Delivery Order SPE2DR25D3104-SPE2DR26FE8XD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Sirolimus 1 mg/ml solution in a 60 ml quantity, with a contract ceiling value of $1,085.44. This non-set-aside delivery order represents a firm fixed-price procurement executed with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Sirolimus 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,007.40 and is classified as a firm fixed price delivery order with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Sirolimus 0.5 mg tablets (100 count) with a ceiling value of $1,393.36. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for ultimate completion by July...
- The Defense Logistics Agency awarded a delivery order valued at $3,168.32 to AmerisourceBergen Drug Corp for the supply of Sirolimus 1 mg tablets in quantities of 100 units. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of December 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,287.56 to AmerisourceBergen Drug Corp for Sirolimus 0.5 mg tablets (100-count packages) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Sirolimus is an immunosuppressant medication commonly used in transplant medicine and...
- This federal contract award, SPE2DX15D1053|SPE2DX24F6NJU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,491.65 firm fixed-price delivery order is for the provision of 100 tablets of the drug Sirolimus 1 mg. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 1, 2025, by the Defense Logistics Agency (DLA) for the supply of Everolimus 5 mg tablets in unit dose packaging. This is a firm fixed-price delivery order with a ceiling value of $1,791.52 and an ultimate completion date of December 2, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a $33,334.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units) with an ultimate completion date of December 18, 2025. This non-competitive delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,856.17 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries an ultimate completion date of August 12, 2025, with performance occurring at...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Everolimus 10 mg tablets in unit dose packaging (28 count). This is a firm fixed-price delivery order with a ceiling value of $1,358.26 and an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE8XDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Sirolimus 1 mg/ml Solution in 60ml quantities, with a ceiling value of $6,938.53 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. The contract utilized no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements. Performance will be executed from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of December 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting the Defense Health Agency and broader military healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This Sirolimus delivery order exemplifies the company's role as a prime vendor within the DLA's pharmaceutical supply chain, supporting the distribution of immunosuppressant medications essential for transplant and other clinical applications within the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/27/25 |